Related Experiment Videos
C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study
Insights
Systemic lupus erythematosus (SLE) patients show reduced complement receptor 1 (CR1)-dependent phagocytosis. This impairment may stem from a functional CR1 defect, not solely genetic factors, suggesting potential links to familial autoimmune disorders.
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease.
- Complement receptor 1 (CR1) plays a crucial role in immune complex clearance.
- Defective CR1 function may contribute to SLE pathogenesis.
Purpose of the Study:
- To investigate CR1-dependent phagocytosis defects in SLE patients.
- To explore the role of CR1 receptor function and genetic background.
- To assess the familial occurrence of CR1 abnormalities in SLE.
Main Methods:
- In vitro phagocytosis assays using C3b-coated erythrocytes and EIgG.
- Analysis of CR1 receptor expression and content in monocytes and polymorphonuclear leukocytes (PMN).
- Family studies including parents and siblings of young SLE patients.
Main Results:
- SLE patients exhibited significantly decreased CR1-dependent phagocytosis of C3b-coated erythrocytes.
- PMN CR1 levels were reduced upon stimulation in SLE patients, despite normal basal expression.
- Healthy relatives of SLE patients showed decreased CR1-dependent phagocytosis, suggesting a functional defect.
- No significant differences in CR1 expression or content were observed between SLE families and controls.
Conclusions:
- Impaired phagocytosis in SLE is likely due to a functional CR1 defect or altered receptor anchorage.
- The findings suggest a potential link between CR1 functional defects and familial autoimmune disorders.
- CR1 abnormalities in SLE may involve functional rather than quantitative or genetic factors.
Abstract:
In vitro CR1-dependent phagocytosis of C3b-coated erythrocytes, by monocytes and PMN, was found to be significantly decreased in SLE patients. This was in many cases related to a specific defect of CR1 receptors, since the FcR-ingestion of EIgG was normal. On the other hand, CR1 levels of PMN stimulated by FMLP were also found to be decreased in SLE patients, while both the expression of circulating PMN (cells isolated at 4 degrees C) and the total cellular CR1 content were normal. On the basis of the available data, we propose that the impaired phagocytosis is due to a functional defect of CR1 or a defective anchorage of the receptor to the plasma membrane, possibly related to the decreased capacity of CR1 to be up-regulated by FMLP. To study the importance of the genetic background in the CR1 abnormalities, the families of 22 young SLE patients, in which the onset of the disease had occurred before the age of 15, were studied. The expression of CR1 on erythrocytes, and the total CR1 content of PMN, in parents and siblings of these patients did not differ significantly from normal controls. By contrast, the ingestion of EIgGC3b by PMN from healthy relatives of these patients was decreased (65% of the normal mean of PI), while EIgG phagocytosis was normal. A relation between this CR1 functional defect and the familial occurrence of autoimmune disorders is therefore possible.